According to the Zhitong Finance App, Yingen Bio-B (09606) announced that on the date of this announcement, the company had purchased a total of 794,200 shares at a total cost of about HK$125 million. All repurchased shares are held by the company as treasury shares.

The board of directors further learned that based on continued confidence in the Group's future development prospects and recognition of the company's long-term investment value, in addition to the initial increase in holdings, Dr. Zhu Zhongyuan, the founder, chairman of the board of directors, executive director and CEO of the company, plans to further increase his holdings in the company by purchasing shares in the open market with his own capital. The total additional amount will not exceed 5 million US dollars. After the further increase in holdings is completed, the total amount of the initial increase and further increase in holdings is expected to be no more than US$10 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.